The company Philips, responsible for a global recall of sleep apnea machines, will not be allowed to resume production in U.S. facilities until safety requirements are met. The settlement requires Philips to overhaul manufacturing and quality control systems, replace or repair defective devices, and hire independent experts to monitor changes. The recall affects over 5 million CPAP machines due to an issue with internal foam breaking down and releasing harmful particles. Lawsuits have been filed by affected users, and regulators are holding Philips accountable for violating safety standards. The FDA warns of potential health risks associated with using the faulty devices.
Source link
Philips ordered to overhaul sleep apnea machine manufacturing
